ES2339132T7 - Metodos y kit para el pronostico de cancer de mama. - Google Patents

Metodos y kit para el pronostico de cancer de mama. Download PDF

Info

Publication number
ES2339132T7
ES2339132T7 ES05763127T ES05763127T ES2339132T7 ES 2339132 T7 ES2339132 T7 ES 2339132T7 ES 05763127 T ES05763127 T ES 05763127T ES 05763127 T ES05763127 T ES 05763127T ES 2339132 T7 ES2339132 T7 ES 2339132T7
Authority
ES
Spain
Prior art keywords
molecular
expression
markers
cancer
genes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES05763127T
Other languages
English (en)
Spanish (es)
Other versions
ES2339132T3 (es
Inventor
Wen Guo Jiang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cardiff Biologicals Ltd
Original Assignee
Cardiff Biologicals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0417740A external-priority patent/GB0417740D0/en
Priority claimed from GB0426777A external-priority patent/GB0426777D0/en
Application filed by Cardiff Biologicals Ltd filed Critical Cardiff Biologicals Ltd
Application granted granted Critical
Publication of ES2339132T3 publication Critical patent/ES2339132T3/es
Publication of ES2339132T7 publication Critical patent/ES2339132T7/es
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Prostheses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
ES05763127T 2004-08-10 2005-07-27 Metodos y kit para el pronostico de cancer de mama. Active ES2339132T7 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0417740 2004-08-10
GB0417740A GB0417740D0 (en) 2004-08-10 2004-08-10 Methods and kit for the prognosis of breast cancer
GB0426777A GB0426777D0 (en) 2004-12-07 2004-12-07 Methods and kit for the prognosis of breast cancer
GB0426777 2004-12-07

Publications (2)

Publication Number Publication Date
ES2339132T3 ES2339132T3 (es) 2010-05-17
ES2339132T7 true ES2339132T7 (es) 2012-03-16

Family

ID=35044601

Family Applications (1)

Application Number Title Priority Date Filing Date
ES05763127T Active ES2339132T7 (es) 2004-08-10 2005-07-27 Metodos y kit para el pronostico de cancer de mama.

Country Status (15)

Country Link
US (1) US20100035240A1 (ja)
EP (1) EP1781814B3 (ja)
JP (2) JP5117852B2 (ja)
CN (1) CN102443627B (ja)
AT (1) ATE454474T1 (ja)
AU (1) AU2005271113B2 (ja)
CA (1) CA2576113A1 (ja)
DE (1) DE602005018789D1 (ja)
DK (1) DK1781814T3 (ja)
ES (1) ES2339132T7 (ja)
GB (1) GB2430741A (ja)
HK (1) HK1103422A1 (ja)
MX (1) MX2007001640A (ja)
PT (1) PT1781814E (ja)
WO (1) WO2006016110A1 (ja)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8497292B2 (en) 2005-12-28 2013-07-30 Translational Therapeutics, Inc. Translational dysfunction based therapeutics
KR100786759B1 (ko) * 2006-07-07 2007-12-18 김현기 Ｈｃｃｒ-1을 포함하는 유방암 예후 마커 및 비만 유도조성물
CN1919874B (zh) * 2006-09-18 2010-09-08 中国人民解放军军事医学科学院生物工程研究所 一种抗尿激酶型纤溶酶激活剂受体的抗体样分子ATF-Fc融合蛋白及其用途
CA2664712C (en) * 2006-09-29 2019-07-09 Translational Therapeutics, Inc. Eif4e regulon-based diagnostics
WO2008138868A2 (en) * 2007-05-09 2008-11-20 Traslational Cancer Drugs Pharma, S.L. In vitro diagnosis and/or prognosis of cancer by the analysis of gtpase protein expression
WO2008150512A2 (en) * 2007-06-04 2008-12-11 University Of Louisville Research Foundation, Inc. Methods for identifying an increased likelihood of recurrence of breast cancer
ES2338843B1 (es) * 2008-07-02 2011-01-24 Centro De Investigaciones Energeticas, Medioambientales Y Tecnologicas Huella genomica de cancer de mama.
US20100081666A1 (en) * 2008-07-14 2010-04-01 Wyeth Src activation for determining cancer prognosis and as a target for cancer therapy
US8735082B2 (en) 2008-11-10 2014-05-27 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Gene signature for predicting prognosis of patients with solid tumors
GB0821787D0 (en) * 2008-12-01 2009-01-07 Univ Ulster A genomic-based method of stratifying breast cancer patients
WO2010128158A1 (en) * 2009-05-08 2010-11-11 Novartis Ag Diagnostic biomarkers for fibrotic disorders
WO2011122857A2 (ko) * 2010-03-30 2011-10-06 서울대학교 산학협력단 유방암 예후 예측을 위한 조성물 및 이를 포함하는 키트
JP2014515821A (ja) * 2011-03-27 2014-07-03 オンコステム ダイアグノスティックス（モーリシャス）プライベート リミテッド 腫瘍細胞を同定するためのマーカー、その方法およびキット
WO2012178128A1 (en) * 2011-06-22 2012-12-27 Oncocyte Corporation Methods and compositions for the treatment and diagnosis of cancer
CA2844793A1 (en) * 2011-08-31 2013-03-07 Oncocyte Corporation Methods and compositions for the treatment and diagnosis of cancer
CN104685065B (zh) 2012-01-20 2017-02-22 俄亥俄州立大学 浸润性和预后的乳腺癌生物标志物标签
FR2988479B1 (fr) * 2012-03-23 2014-12-19 Hospices Civils Lyon Procede de determination de la susceptibilite aux infections nosocomiales
KR101672531B1 (ko) * 2013-04-18 2016-11-17 주식회사 젠큐릭스 조기 유방암 예후 예측 진단용 유전자 마커 및 이의 용도
CN103235141A (zh) * 2013-04-27 2013-08-07 上海交通大学医学院附属新华医院 Atf3用于预测膀胱癌转移和判断预后的应用
KR101548830B1 (ko) * 2013-12-30 2015-08-31 가천대학교 산학협력단 줄기세포 배양방법을 이용하여 발굴된 유방암 줄기세포 마커를 이용한 유방암 예후 예측용 조성물
JP6711968B2 (ja) * 2014-01-10 2020-06-17 学校法人順天堂 子宮体がんのリンパ節転移能の評価方法
CA2947198C (en) * 2014-04-29 2023-01-17 Novartis Ag Novel vertebrate cells and methods for recombinantly expressing a polypeptide of interest
CN105986024B (zh) * 2015-02-27 2019-10-25 复旦大学附属肿瘤医院 一组用于三阴性乳腺癌预后的基因及其应用
CN104725487A (zh) * 2015-04-06 2015-06-24 苏州普罗达生物科技有限公司 紧密连接蛋白抑制剂多肽及其应用
CN104725488A (zh) * 2015-04-06 2015-06-24 苏州普罗达生物科技有限公司 关于紧密连接蛋白抑制剂多肽及其应用
CN106295244B (zh) * 2015-06-05 2019-09-17 上海交通大学医学院附属瑞金医院 肿瘤诊断标志物的筛选方法、以该方法获得的乳腺癌肺转移相关基因及其应用
SG11201707815RA (en) 2015-06-05 2017-12-28 Novartis Ag Antibodies targeting bone morphogenetic protein 9 (bmp9) and methods therefor
WO2017007031A1 (ja) * 2015-07-09 2017-01-12 学校法人順天堂 子宮体がんのリンパ節転移能の評価方法
CN106337081B (zh) * 2016-02-02 2020-01-21 中国医学科学院肿瘤医院 FABP4基因的SNP位点rs1054135与三阴型乳腺癌预后的相关性
WO2018074865A2 (ko) * 2016-10-21 2018-04-26 서울대학교병원 유방암 예후 예측용 조성물 및 방법
EP3364190A1 (en) * 2017-02-20 2018-08-22 Panka Cancer Research AG Method of detecting cancer or cancer cells
TW201834698A (zh) * 2017-03-03 2018-10-01 國立研究開發法人國立癌症研究中心 抗ｉｌ－７ｒ抗體之抗體藥物共軛物與處置癌或發炎用之包含抗ｉｌ－７ｒ抗體與細胞傷害劑之抗體藥物共軛物之醫藥組成物
CN108504726B (zh) * 2018-03-28 2021-10-26 华南农业大学 采用amf单个孢子微量dna进行pcr预处理的方法
WO2020008097A2 (es) * 2018-07-03 2020-01-09 Universidad De Granada Método de obtención de datos útiles para predecir o pronosticar la supervivencia global y la supervivencia libre de recaídas en el cáncer y composición capaz de modular la actividad de atf4 para el tratamiento del cáncer
CN109620832B (zh) * 2019-01-14 2021-01-01 大连大学 甘氨胆酸在制备抗乳腺增生药物中的应用
KR102280672B1 (ko) * 2019-12-20 2021-07-23 주식회사 베르티스 암의 진단용 조성물
CN114758773A (zh) * 2022-05-25 2022-07-15 四川大学华西医院 一种膀胱癌免疫治疗生物标志物、免疫风险模型及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5759791A (en) * 1989-01-17 1998-06-02 The Johns Hopkins University Cancer related antigen
CA2164498C (en) * 1993-07-09 2007-09-11 Paul A. Price Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices
CA2279575A1 (en) * 1997-02-06 1998-08-13 Genetics Institute, Inc. Human sdf-5 protein and compositions
AU2351699A (en) * 1998-01-30 1999-08-16 Brigham And Women's Hospital The human calcium-sensing receptor in the detection and treatment of cancer
AU1616700A (en) * 1998-11-13 2000-06-05 Curis, Inc. Methods of alleviating cancer symptoms
WO2002059377A2 (en) * 2001-01-24 2002-08-01 Protein Design Labs Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
US20030064384A1 (en) * 2001-04-02 2003-04-03 Mien-Chie Hung Beta-catenin is a strong and independent prognostic factor for cancer
US20040086504A1 (en) * 2001-06-21 2004-05-06 Deepak Sampath Cyr61 as a target for treatment and diagnosis of breast cancer
WO2003050307A1 (en) * 2001-12-05 2003-06-19 Genzyme Corporation Compounds for therapy and diagnosis and methods for using same
WO2003054165A2 (en) * 2001-12-20 2003-07-03 The Regents Of The University Of California Genetic markers and methods for the diagnosis, treatment and prevention of tumor metastasis
US20030186248A1 (en) * 2002-03-29 2003-10-02 Erlander Mark G. Interpreting cytological specimens via molecular histological signatures
US20040231909A1 (en) * 2003-01-15 2004-11-25 Tai-Yang Luh Motorized vehicle having forward and backward differential structure

Also Published As

Publication number Publication date
EP1781814B3 (en) 2011-08-31
HK1103422A1 (en) 2007-12-21
CN102443627A (zh) 2012-05-09
JP2008508895A (ja) 2008-03-27
GB0701676D0 (en) 2007-03-14
JP5634360B2 (ja) 2014-12-03
DE602005018789D1 (de) 2011-05-26
AU2005271113B2 (en) 2010-12-09
WO2006016110A1 (en) 2006-02-16
JP5117852B2 (ja) 2013-01-16
WO2006016110A8 (en) 2006-08-24
EP1781814B1 (en) 2010-01-06
ES2339132T3 (es) 2010-05-17
CA2576113A1 (en) 2006-02-16
MX2007001640A (es) 2007-07-25
JP2012024095A (ja) 2012-02-09
CN102443627B (zh) 2014-10-29
ATE454474T1 (de) 2010-01-15
DK1781814T3 (da) 2010-05-03
EP1781814A1 (en) 2007-05-09
PT1781814E (pt) 2010-04-12
US20100035240A1 (en) 2010-02-11
AU2005271113A1 (en) 2006-02-16
GB2430741A (en) 2007-04-04

Similar Documents

Publication Publication Date Title
ES2339132T7 (es) Metodos y kit para el pronostico de cancer de mama.
ES2304306B1 (es) Metodo de diagnostico y/o pronostico de cancer vesical.
CN101014720B (zh) 用于乳腺癌的预后的方法和试剂盒
Min et al. S100A4 expression is associated with lymph node metastasis in papillary microcarcinoma of the thyroid
ES2647154T3 (es) Combinaciones de biomarcadores para tumores colorrectales
US20130137603A1 (en) Newly identified colon cancer marker and diagnostic kit using the same
CN103562404A (zh) 预测肝癌预后的组合物或试剂盒以及预测肝癌预后的方法
US20140371081A1 (en) Compositions for and Methods of Detecting, Diagnosing, and Prognosing Thymic Cancer
KR20180030347A (ko) 폐암 질환의 진단용 마커
CN110331207A (zh) 肺腺癌生物标志物及相关应用
Semik-Gurgul et al. DNA methylation patterns of the S100A14, POU2F3 and SFN genes in equine sarcoid tissues
US9051619B2 (en) Methods and compositions for prostate cancer metastasis
ES2363669B1 (es) Metodo para determinar el riesgo de desarrollar metastasis cerebral y un kit para llevar a cabo dicho procedimiento
US20120156681A1 (en) Composition for diagnosis of liver metastasis of colorectal cancer and the use thereof
KR102178432B1 (ko) 침윤성 뇌암의 진단용 조성물
KR102416607B1 (ko) 방사선 저항성 지표 단백질 및 이의 검출방법
ES2343996B1 (es) Metodo para la subclasificacion de tumores.
EP3321683A1 (en) Method for evaluating lymph node metastatic potential of endometrial cancer
ES2292348B2 (es) Metodo y kit de diagnostico precoz y/o pronostico del carcinoma oral de celulas escamosas (coce).
KR102416614B1 (ko) 방사선 저항성 지표 단백질 및 이의 검출방법
KR102133432B1 (ko) 폐암 질환의 진단용 마커
ES2628150T3 (es) Métodos y productos para pronosticar la evolución clínica o predecir el riesgo de recidiva de una lesión papilar de mama
KR101179651B1 (ko) 피부 편평세포암 진단 또는 예후 마커인 ｎｑｏ-1 및 이의 용도
KR101188693B1 (ko) 피부 편평세포암 진단 또는 예후 마커인 ＰｒｘⅠ 및 이의 용도
KR20200038045A (ko) 방광암 수술치료법 결정을 위한 유전자 세트